Evidence map›Paper›PMID 37730439›Full record

ArticleNeurology2023

The Brain Health Imperative in the 21st Century-A Call to Action: The AAN Brain Health Platform and Position Statement.

Natalia S Rost, Joel Salinas, Justin T Jordan, Brenda Banwell, Daniel J Correa, Rana R Said, Linda M Selwa, Sarah Song, David A Evans, American Academy of Neurology's Committee on Public Engagement

Abstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Trial
  2. [Modifiable risk and protective factors for dementia: an overview of established and emerging evidence].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Shaping the scientific agenda: Defining and operationalizing brain health in aging.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  7. Global Socioeconomic Context and Brain Ageing in Epilepsy: an ENIGMA-Epilepsy study.medRxiv : the preprint server for health sciences · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Health disparities in neurology.Nature reviews. Neurology · 2025
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Natalia S RostFrom the Department of Neurology (N.S.R., J.T.J.), Massachusetts General Hospital, Harvard Medical School, Boston, MA; Division of Child Neurology (B.B.), Children's Hospital of Philadelphia; Departments of Neurology and Pediatrics (B.B), University of Pennsylvania, PA; Department of Neurology (J.S.), New York University Langone Health, New York University Grossman School of Medicine, New York, NY; Saul Korey Department of Neurology & Comprehensive Epilepsy Center (D.J.C.), Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; Department of Pediatrics, Division of Pediatric Neurology (R.R.S.), University of Texas Southwestern Medical Center, Dallas, TX; Department of Neurology (L.M.S.), University of Michigan Medical Center, Ann Arbor, MI; Department of Neurology (S.S.), Rush University Medical Center, Chicago, IL; and Texas Neurology (D.A.E.), Dallas. nrost@mgb.org.
Joel SalinasFrom the Department of Neurology (N.S.R., J.T.J.), Massachusetts General Hospital, Harvard Medical School, Boston, MA; Division of Child Neurology (B.B.), Children's Hospital of Philadelphia; Departments of Neurology and Pediatrics (B.B), University of Pennsylvania, PA; Department of Neurology (J.S.), New York University Langone Health, New York University Grossman School of Medicine, New York, NY; Saul Korey Department of Neurology & Comprehensive Epilepsy Center (D.J.C.), Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; Department of Pediatrics, Division of Pediatric Neurology (R.R.S.), University of Texas Southwestern Medical Center, Dallas, TX; Department of Neurology (L.M.S.), University of Michigan Medical Center, Ann Arbor, MI; Department of Neurology (S.S.), Rush University Medical Center, Chicago, IL; and Texas Neurology (D.A.E.), Dallas.ORCID 0000-0002-3735-0018
Justin T JordanFrom the Department of Neurology (N.S.R., J.T.J.), Massachusetts General Hospital, Harvard Medical School, Boston, MA; Division of Child Neurology (B.B.), Children's Hospital of Philadelphia; Departments of Neurology and Pediatrics (B.B), University of Pennsylvania, PA; Department of Neurology (J.S.), New York University Langone Health, New York University Grossman School of Medicine, New York, NY; Saul Korey Department of Neurology & Comprehensive Epilepsy Center (D.J.C.), Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; Department of Pediatrics, Division of Pediatric Neurology (R.R.S.), University of Texas Southwestern Medical Center, Dallas, TX; Department of Neurology (L.M.S.), University of Michigan Medical Center, Ann Arbor, MI; Department of Neurology (S.S.), Rush University Medical Center, Chicago, IL; and Texas Neurology (D.A.E.), Dallas.
Brenda BanwellFrom the Department of Neurology (N.S.R., J.T.J.), Massachusetts General Hospital, Harvard Medical School, Boston, MA; Division of Child Neurology (B.B.), Children's Hospital of Philadelphia; Departments of Neurology and Pediatrics (B.B), University of Pennsylvania, PA; Department of Neurology (J.S.), New York University Langone Health, New York University Grossman School of Medicine, New York, NY; Saul Korey Department of Neurology & Comprehensive Epilepsy Center (D.J.C.), Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; Department of Pediatrics, Division of Pediatric Neurology (R.R.S.), University of Texas Southwestern Medical Center, Dallas, TX; Department of Neurology (L.M.S.), University of Michigan Medical Center, Ann Arbor, MI; Department of Neurology (S.S.), Rush University Medical Center, Chicago, IL; and Texas Neurology (D.A.E.), Dallas.
Daniel J CorreaFrom the Department of Neurology (N.S.R., J.T.J.), Massachusetts General Hospital, Harvard Medical School, Boston, MA; Division of Child Neurology (B.B.), Children's Hospital of Philadelphia; Departments of Neurology and Pediatrics (B.B), University of Pennsylvania, PA; Department of Neurology (J.S.), New York University Langone Health, New York University Grossman School of Medicine, New York, NY; Saul Korey Department of Neurology & Comprehensive Epilepsy Center (D.J.C.), Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; Department of Pediatrics, Division of Pediatric Neurology (R.R.S.), University of Texas Southwestern Medical Center, Dallas, TX; Department of Neurology (L.M.S.), University of Michigan Medical Center, Ann Arbor, MI; Department of Neurology (S.S.), Rush University Medical Center, Chicago, IL; and Texas Neurology (D.A.E.), Dallas.ORCID 0000-0002-6490-9331
Rana R SaidFrom the Department of Neurology (N.S.R., J.T.J.), Massachusetts General Hospital, Harvard Medical School, Boston, MA; Division of Child Neurology (B.B.), Children's Hospital of Philadelphia; Departments of Neurology and Pediatrics (B.B), University of Pennsylvania, PA; Department of Neurology (J.S.), New York University Langone Health, New York University Grossman School of Medicine, New York, NY; Saul Korey Department of Neurology & Comprehensive Epilepsy Center (D.J.C.), Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; Department of Pediatrics, Division of Pediatric Neurology (R.R.S.), University of Texas Southwestern Medical Center, Dallas, TX; Department of Neurology (L.M.S.), University of Michigan Medical Center, Ann Arbor, MI; Department of Neurology (S.S.), Rush University Medical Center, Chicago, IL; and Texas Neurology (D.A.E.), Dallas.
Linda M SelwaFrom the Department of Neurology (N.S.R., J.T.J.), Massachusetts General Hospital, Harvard Medical School, Boston, MA; Division of Child Neurology (B.B.), Children's Hospital of Philadelphia; Departments of Neurology and Pediatrics (B.B), University of Pennsylvania, PA; Department of Neurology (J.S.), New York University Langone Health, New York University Grossman School of Medicine, New York, NY; Saul Korey Department of Neurology & Comprehensive Epilepsy Center (D.J.C.), Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; Department of Pediatrics, Division of Pediatric Neurology (R.R.S.), University of Texas Southwestern Medical Center, Dallas, TX; Department of Neurology (L.M.S.), University of Michigan Medical Center, Ann Arbor, MI; Department of Neurology (S.S.), Rush University Medical Center, Chicago, IL; and Texas Neurology (D.A.E.), Dallas.ORCID 0000-0001-9539-5225
Sarah SongFrom the Department of Neurology (N.S.R., J.T.J.), Massachusetts General Hospital, Harvard Medical School, Boston, MA; Division of Child Neurology (B.B.), Children's Hospital of Philadelphia; Departments of Neurology and Pediatrics (B.B), University of Pennsylvania, PA; Department of Neurology (J.S.), New York University Langone Health, New York University Grossman School of Medicine, New York, NY; Saul Korey Department of Neurology & Comprehensive Epilepsy Center (D.J.C.), Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; Department of Pediatrics, Division of Pediatric Neurology (R.R.S.), University of Texas Southwestern Medical Center, Dallas, TX; Department of Neurology (L.M.S.), University of Michigan Medical Center, Ann Arbor, MI; Department of Neurology (S.S.), Rush University Medical Center, Chicago, IL; and Texas Neurology (D.A.E.), Dallas.
David A EvansFrom the Department of Neurology (N.S.R., J.T.J.), Massachusetts General Hospital, Harvard Medical School, Boston, MA; Division of Child Neurology (B.B.), Children's Hospital of Philadelphia; Departments of Neurology and Pediatrics (B.B), University of Pennsylvania, PA; Department of Neurology (J.S.), New York University Langone Health, New York University Grossman School of Medicine, New York, NY; Saul Korey Department of Neurology & Comprehensive Epilepsy Center (D.J.C.), Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; Department of Pediatrics, Division of Pediatric Neurology (R.R.S.), University of Texas Southwestern Medical Center, Dallas, TX; Department of Neurology (L.M.S.), University of Michigan Medical Center, Ann Arbor, MI; Department of Neurology (S.S.), Rush University Medical Center, Chicago, IL; and Texas Neurology (D.A.E.), Dallas.
American Academy of Neurology's Committee on Public Engagement

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain health is crucial to optimizing both the function and well-being of every person at each stage of life and is key to both individual and social progress. As a concept, brain health is complex and requires a multidisciplinary collaborative approach between many professional and public organizations to bring into effect meaningful change. Neurologists are uniquely positioned to serve as specialists in brain health and to advance the newly evolving field of preventive neurology, which aims to identify individuals at high risk of brain disorders and other neurologic conditions and offer strategies to mitigate disease emergence or progression. For decades, the American Academy of Neurology (AAN) has demonstrated a commitment to brain health through its public outreach and advocacy. The AAN's Brain Health Initiative launched in 2022 with a strategic plan prioritizing brain health as a key aspect of public engagement and positioning the AAN and neurologists as champions of brain health in collaboration with a broad range of other brain health providers. In this study, we present (1) the new definition of brain health developed by the AAN for neurologists, patients, partners in health care, and the public; (2) the strategic objectives of the AAN Brain Health Initiative; and (3) the AAN Brain Health Platform and Action Plan framework, including key positions on brain health, its 3 ambitious goals, and a national brain health vision. The top-line priorities of the AAN Brain Health Action Plan highlight the need for research, education, public policy, and direct-to-public messaging across the individual's life span and will serve as a catalyst for future cross-disciplinary collaborations within each epoch and longitudinally. The AAN Brain Health Platform is designed to communicate the AAN's vision for brain health and provide a blueprint toward achieving the future of optimal brain health across the life span for all. Through this position statement, we call upon neurologists and other stakeholders in brain health to join our collective efforts to accomplish the ultimate goal of transforming the current trajectory of public health of an increasing burden of neurologic disorders-from both illness and injury-to achieving optimal brain health for all.

Indexed as

Brain DiseasesNeurologyAcademies and InstitutesBrainHumansNeurologists

Identifiers

PMID37730439
PMCPMC10558159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.